PATENT CLAIM ANALYSIS

Application Number: 16179116
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-02
Patent Classification: ["514", "04400R"]

Abstract:
The disclosure relates to compositions and methods for the preparation, manufacture and therapeutic use of polynucleotides encoding AADC for the treatment, prophylaxis, palliation or amelioration of diseases, conditions and/or symptoms resulting from AADC deficiency and related inborn errors of neurotransmitter metabolism.

Claim (Index 13):
The method of  claim 12 , wherein the poly(A) signal is derived from a simian virus 40 (SV40) gene.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 98.0
- Lexical Diversity: 1.27778
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15524986', '15191357', '15209363', '14803683', '15127757']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7255670048503573
- 35 USC 102 Novelty (BERT): 0.5090222329802389
- Combined Prediction Score: 0.7039125276633454
- Mean Citation Score: 235.511034
- Max Citation Score: 268.0934
- Similarity Product: 190.75522651518585

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test